S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › LENT › Research report
← LENT page
XStocksXray
Market X-Ray report · 19 October 2026

MK Lenta PAO (LENT)

Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026

Key indicators

Last closeRUB 1,760.00
52-week range1,556.00 – 2,300.00
Return, 1 month / 3 months+8.7% / −3.3%
Return, 1 year / 3 years+5.5% / +137.7%
TrendBelow its 200-day average
RSI (14)50
Volatility (1 year)29.8%
Worst drawdown (1 year)-30.6%
Average daily value traded129.66M RUB
Dividend yield–

Market X-Ray price-based

65/ 100 · High confidence · ahead of 80% of stocks on this exchange
Trend61
Momentum43
Stability (higher is calmer)82
Liquidity78
Income–

Five-year price chart navy: price · brown: 200-day average

5039691,4351,9012,3672021-122023-032024-052025-082026-10

About the company

Lenta is a Russian food retailer that runs hypermarkets and supermarkets in cities across the country. Its stores offer groceries, household goods, clothing and other everyday products to ordinary shoppers, combining large-format outlets with smaller neighbourhood supermarkets. The company is based in Russia and serves customers through its own retail network, sourcing food and consumer goods for households and families.

On this site MK Lenta PAO appears as a stock on the Moscow Exchange (Russia), code LENT, with prices in Russian rubles (RUB). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

MK Lenta PAO (LENT) trades on the Moscow Exchange in Russia. It last closed at RUB 1,760.00 on 19 October 2026.

Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 50 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 5.5% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
MK Lenta PAO (LENT)

The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange

Lens and metricValueScoreReading
Trend61 · FairMixed trend against its averages.
Above 200-day average-8.5%
From 52-week high-22.4%
Momentum43 · WeakLagging most stocks on this exchange.
3-month return-3.3%
6-month return-19.3%
12-month return, skipping the last month-2.9%
Stability (higher is calmer)82 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)29.8%
Worst drawdown, 1 year (smaller is calmer)-30.6%
Liquidity78 · StrongTrades actively.
Average daily value traded129.66M RUB
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
  • Liquidity: Trades actively.

Weak spots

  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−0.2%
1 month+8.7%
3 months−3.3%
6 months−19.3%
1 year+5.5%
3 years+137.7%
5 years–

Signals

50-day / 200-day average1,797.94 / 1,923.71
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)53.55

Technical summary

DailyBearish3 bullish · 4 neutral · 9 bearish
WeeklyBearish3 bullish · 1 neutral · 8 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026